Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
153.40
+2.26 (1.50%)
At close: Apr 14, 2026, 4:00 PM EDT
152.45
-0.95 (-0.62%)
After-hours: Apr 14, 2026, 7:13 PM EDT
Insmed Stock Forecast
Stock Price Forecast
The 23 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $201.17, which forecasts a 31.14% increase in the stock price over the next year. The lowest target is $120 and the highest is $245.
Price Target: $201.17 (+31.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 12 | 12 | 13 | 13 |
| Buy | 7 | 9 | 10 | 9 | 10 | 10 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 21 | 24 | 23 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $212 → $216 | Buy | Maintains | $212 → $216 | +40.81% | Apr 14, 2026 |
| Barclays | Barclays | Buy Maintains $231 → $237 | Buy | Maintains | $231 → $237 | +54.50% | Apr 1, 2026 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $166 → $212 | Hold → Buy | Upgrades | $166 → $212 | +38.20% | Mar 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $230 → $245 | Strong Buy | Maintains | $230 → $245 | +59.71% | Mar 26, 2026 |
| Mizuho | Mizuho | Buy Maintains $204 → $206 | Buy | Maintains | $204 → $206 | +34.29% | Mar 25, 2026 |
Financial Forecast
Revenue This Year
1.68B
from 606.42M
Increased by 177.03%
Revenue Next Year
2.80B
from 1.68B
Increased by 66.55%
EPS This Year
-2.95
from -6.42
EPS Next Year
0.69
from -2.95
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.0B | 3.8B | |||
| Avg | 1.7B | 2.8B | |||
| Low | 949.6M | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 236.7% | 124.6% | |||
| Avg | 177.0% | 66.5% | |||
| Low | 56.6% | 13.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.65 | 2.56 | |||
| Avg | -2.95 | 0.69 | |||
| Low | -5.02 | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.